AGIOS PHARMACEUTICALS, INC. (AGIO) Free cash flow 2016–2025
AGIOS PHARMACEUTICALS, INC. (AGIO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$377.3MFY2025 · since FY2016: $28.6M → -$377.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$377.3M | +3.6% |
| FY2024 | -$391.5M | -31.8% |
| FY2023 | -$297.1M | +5.5% |
| FY2022 | -$314.4M | +23.9% |
| FY2021 | -$413.1M | -35.5% |
| FY2020 | -$304.9M | +20.3% |
| FY2019 | -$382.6M | -22.9% |
| FY2018 | -$311.4M | -7.4% |
| FY2017 | -$289.9M | -1111.8% |
| FY2016 | $28.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More AGIO financial trends
AGIO RevenueAGIO Net incomeAGIO Net marginAGIO Gross profitAGIO Gross marginAGIO Operating incomeAGIO Operating marginAGIO Operating cash flowAGIO Capital expendituresAGIO Return on equityAGIO Stock buybacksAGIO Dividends paidAGIO Total assetsAGIO Total liabilitiesAGIO Shareholders’ equityAGIO overview →